3.1
This guidance requires that clinicians undertaking the procedure make special arrangements for audit. NICE has identified relevant audit criteria and developed an audit tool (which is for use at local discretion).
3 Further information
3.2
NICE has issued guidelines on type 1 diabetes in adults, diabetes (type 1 and type 2) in children and young people and diabetic foot problems. NICE has also issued HealthTech guidance on allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitus, and technology appraisal guidance on continuous subcutaneous insulin infusion for the treatment of diabetes mellitus.